smatrial.enl EndNote 626 17 <style face="normal" font="default" size="100%">(R,S)-salbutamol plasma concentrations in severe asthma</style> smatrial.enl EndNote 4 17 <style face="normal" font="default" size="100%">134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy, 11-13 February 2005, Naarden, The Netherlands</style> smatrial.enl EndNote 1071 17 <style face="normal" font="default" size="100%">157th ENMC International Workshop: patient registries for rare, inherited muscular disorders 25-27 January 2008 Naarden, The Netherlands</style> smatrial.enl EndNote 439 17 <style face="normal" font="default" size="100%">17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration</style> smatrial.enl EndNote 997 17 <style face="normal" font="default" size="100%">17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse</style> smatrial.enl EndNote 250 17 <style face="normal" font="default" size="100%">2 Years' experience with inspiratory muscle training in patients with neuromuscular disorders</style> smatrial.enl EndNote 554 17 <style face="normal" font="default" size="100%">2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure</style> smatrial.enl EndNote 807 17 <style face="normal" font="default" size="100%">4th UK spinal muscular atrophy (SMA) researchers network meeting</style> smatrial.enl EndNote 76 17 <style face="normal" font="default" size="100%">59th ENMC International Workshop: Spinal Muscular Atrophies: recent progress and revised diagnostic criteria 17-19 April 1998, Soestduinen, The Netherlands</style> smatrial.enl EndNote 415 17 <style face="normal" font="default" size="100%">A beginner's guide to NF-kappaB signaling pathways</style> smatrial.enl EndNote 349 17 <style face="normal" font="default" size="100%">A behavioural characterisation of the FVB/N mouse strain</style> smatrial.enl EndNote 319 17 <style face="normal" font="default" size="100%">A cell system with targeted disruption of the SMN gene: functional conservation of the SMN protein and dependence of Gemin2 on SMN</style> smatrial.enl EndNote 365 17 <style face="normal" font="default" size="100%">A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients</style> smatrial.enl EndNote 587 17 <style face="normal" font="default" size="100%">A comprehensive interaction map of the human SMN-complex</style> smatrial.enl EndNote 1005 17 <style face="normal" font="default" size="100%">A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis</style> smatrial.enl EndNote 1407 17 <style face="normal" font="default" size="100%">A defined long-term in vitro tissue engineered model of neuromuscular junctions</style> smatrial.enl EndNote 1392 17 <style face="normal" font="default" size="100%">A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity</style> smatrial.enl EndNote 292 17 <style face="normal" font="default" size="100%">A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy</style> smatrial.enl EndNote 866 17 <style face="normal" font="default" size="100%">A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome</style> smatrial.enl EndNote 600 17 <style face="normal" font="default" size="100%">A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle</style> smatrial.enl EndNote 937 17 <style face="normal" font="default" size="100%">A Dutch guideline for the treatment of scoliosis in neuromuscular disorders</style> smatrial.enl EndNote 510 17 <style face="normal" font="default" size="100%">A feasibility study for the newborn screening of spinal muscular atrophy</style> smatrial.enl EndNote 1422 17 <style face="normal" font="default" size="100%">A first step in viral gene therapy for muscular dystrophy</style> smatrial.enl EndNote 247 17 <style face="normal" font="default" size="100%">A flexible data analysis tool for chemical genetic screens</style> smatrial.enl EndNote 968 17 <style face="normal" font="default" size="100%">A Handheld Electrical Impedance Myography probe for the assessment of neuromuscular disease</style> smatrial.enl EndNote 503 17 <style face="normal" font="default" size="100%">A high-throughput drug screen targeted to the 5'untranslated region of Alzheimer amyloid precursor protein mRNA</style> smatrial.enl EndNote 1319 17 <style face="normal" font="default" size="100%">A homozygous mutation in the SCO2 gene causes a spinal muscular atrophy like presentation with stridor and respiratory insufficiency</style> smatrial.enl EndNote 417 17 <style face="normal" font="default" size="100%">A microarray configuration to quantify expression levels and relative abundance of splice variants</style> smatrial.enl EndNote 487 17 <style face="normal" font="default" size="100%">A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy</style> smatrial.enl EndNote 1002 17 <style face="normal" font="default" size="100%">A motor function for the DEAD-box RNA helicase, Gemin3, in Drosophila</style> smatrial.enl EndNote 1301 17 <style face="normal" font="default" size="100%">A motor function measure for neuromuscular diseases. Construction and validation study</style> smatrial.enl EndNote 241 17 <style face="normal" font="default" size="100%">A mouse model for spinal muscular atrophy</style> smatrial.enl EndNote 578 17 <style face="normal" font="default" size="100%">A mouse model of spinal and bulbar muscular atrophy</style> smatrial.enl EndNote 1306 17 <style face="normal" font="default" size="100%">A multistep validation process of biomarkers for preclinical drug development</style> smatrial.enl EndNote 401 17 <style face="normal" font="default" size="100%">A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes</style> smatrial.enl EndNote 116 17 <style face="normal" font="default" size="100%">A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis</style> smatrial.enl EndNote 1037 17 <style face="normal" font="default" size="100%">A natural history study of late onset spinal muscular atrophy types 3b and 4</style> smatrial.enl EndNote 104 17 <style face="normal" font="default" size="100%">A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy</style> smatrial.enl EndNote 914 17 <style face="normal" font="default" size="100%">A Negatively-Acting Bifunctional RNA Increases Survival Motor Neuron in vitro and in vivo</style> smatrial.enl EndNote 716 17 <style face="normal" font="default" size="100%">A new splice site mutation in the SMN1 gene causes discrepant results in SMN1 deletion screening approaches</style> smatrial.enl EndNote 299 17 <style face="normal" font="default" size="100%">A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels</style> smatrial.enl EndNote 158 17 <style face="normal" font="default" size="100%">A novel association of the SMN protein with two major non-ribosomal nucleolar proteins and its implication in spinal muscular atrophy</style> smatrial.enl EndNote 339 17 <style face="normal" font="default" size="100%">A novel cell immunoassay to measure survival of motor neurons protein in blood cells</style> smatrial.enl EndNote 174 17 <style face="normal" font="default" size="100%">A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing</style> smatrial.enl EndNote 582 17 <style face="normal" font="default" size="100%">A novel method for oral delivery of drug compounds to the neonatal SMNDelta7 mouse model of spinal muscular atrophy</style> smatrial.enl EndNote 165 17 <style face="normal" font="default" size="100%">A novel nuclear structure containing the survival of motor neurons protein</style> smatrial.enl EndNote 631 17 <style face="normal" font="default" size="100%">A novel peroxisome proliferator-activated receptor (PPAR)gamma agonist, NIP-222, reduces urinary albumin excretion in streptozotocin-diabetic mice independent of PPARgamma activation</style> smatrial.enl EndNote 915 17 <style face="normal" font="default" size="100%">A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS</style> smatrial.enl EndNote 282 17 <style face="normal" font="default" size="100%">A phase 1 trial of riluzole in spinal muscular atrophy</style> smatrial.enl EndNote 263 17 <style face="normal" font="default" size="100%">A placebo-controlled trial of gabapentin in spinal muscular atrophy</style> smatrial.enl EndNote 976 17 <style face="normal" font="default" size="100%">A population-based study of genotypic and phenotypic variability in children with spinal muscular atrophy</style> smatrial.enl EndNote 233 17 <style face="normal" font="default" size="100%">A predominantly nuclear protein affecting cytoplasmic localization of beta-actin mRNA in fibroblasts and neurons</style> smatrial.enl EndNote 794 17 <style face="normal" font="default" size="100%">A preliminary report on spinal muscular atrophy lymphoblastoid cell lines: Are they an appropriate tool for drug screening?</style> smatrial.enl EndNote 848 17 <style face="normal" font="default" size="100%">A presynaptic giant ankyrin stabilizes the NMJ through regulation of presynaptic microtubules and transsynaptic cell adhesion</style> smatrial.enl EndNote 1414 17 <style face="normal" font="default" size="100%">A randomized study of alglucosidase alfa in late-onset Pompe's disease</style> smatrial.enl EndNote 361 17 <style face="normal" font="default" size="100%">A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease</style> smatrial.enl EndNote 1294 17 <style face="normal" font="default" size="100%">A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy</style> smatrial.enl EndNote 1225 17 <style face="normal" font="default" size="100%">A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease</style> smatrial.enl EndNote 192 17 <style face="normal" font="default" size="100%">A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes</style> smatrial.enl EndNote 24 17 <style face="normal" font="default" size="100%">A role for complexes of survival of motor neurons (SMN) protein with gemins and profilin in neurite-like cytoplasmic extensions of cultured nerve cells</style> smatrial.enl EndNote 674 17 <style face="normal" font="default" size="100%">A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy</style> smatrial.enl EndNote 1124 17 <style face="normal" font="default" size="100%">A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy</style> smatrial.enl EndNote 1066 17 <style face="normal" font="default" size="100%">A simple multiplex real-time PCR methodology for the SMN1 gene copy number quantification</style> smatrial.enl EndNote 437 17 <style face="normal" font="default" size="100%">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</style> smatrial.enl EndNote 18 17 <style face="normal" font="default" size="100%">A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2</style> smatrial.enl EndNote 1083 17 <style face="normal" font="default" size="100%">A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice</style> smatrial.enl EndNote 872 17 <style face="normal" font="default" size="100%">A SMNDelta7 read-through product confers functionality to the SMNDelta7 protein</style> smatrial.enl EndNote 1418 17 <style face="normal" font="default" size="100%">A spatio-temporal analysis of motoneuron survival, axonal regeneration and neurotrophic factor expression after lumbar ventral root avulsion and implantation</style> smatrial.enl EndNote 1054 17 <style face="normal" font="default" size="100%">A splicing component adapted to gene silencing</style> smatrial.enl EndNote 216 17 <style face="normal" font="default" size="100%">A survival motor neuron:tetanus toxin fragment C fusion protein for the targeted delivery of SMN protein to neurons</style> smatrial.enl EndNote 20 17 <style face="normal" font="default" size="100%">A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy</style> smatrial.enl EndNote 881 17 <style face="normal" font="default" size="100%">A two-site ELISA can quantify upregulation of SMN protein by drugs for spinal muscular atrophy</style> smatrial.enl EndNote 357 17 <style face="normal" font="default" size="100%">A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS</style> smatrial.enl EndNote 1058 17 <style face="normal" font="default" size="100%">Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity</style> smatrial.enl EndNote 1375 17 <style face="normal" font="default" size="100%">Aberrant RNA processing events in neurological disorders</style> smatrial.enl EndNote 545 17 <style face="normal" font="default" size="100%">Abnormal fatty acid metabolism in childhood spinal muscular atrophy</style> smatrial.enl EndNote 1264 17 <style face="normal" font="default" size="100%">Abnormal Mitochondrial Dynamics and Neurodegenerative Diseases</style> smatrial.enl EndNote 871 17 <style face="normal" font="default" size="100%">Abnormal motoneuron migration, differentiation, and axon outgrowth in spinal muscular atrophy</style> smatrial.enl EndNote 664 17 <style face="normal" font="default" size="100%">Abnormal motor phenotype in the SMNDelta7 mouse model of spinal muscular atrophy</style> smatrial.enl EndNote 1238 17 <style face="normal" font="default" size="100%">Abnormal serum concentrations of proteins in Parkinson's disease</style> smatrial.enl EndNote 952 17 <style face="normal" font="default" size="100%">Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis</style> smatrial.enl EndNote 321 17 <style face="normal" font="default" size="100%">Abolishing Bax-Dependent Apoptosis Shows Beneficial Effects on Spinal Muscular Atrophy Model Mice</style> smatrial.enl EndNote 133 17 <style face="normal" font="default" size="100%">Abolishing Trp53-dependent apoptosis does not benefit spinal muscular atrophy model mice</style> smatrial.enl EndNote 811 17 <style face="normal" font="default" size="100%">AChR channel conversion and AChR-adjusted neuronal survival during embryonic development</style> smatrial.enl EndNote 1 17 <style face="normal" font="default" size="100%">Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients</style> smatrial.enl EndNote 1106 17 <style face="normal" font="default" size="100%">ACOG Committee Opinion No. 432: Spinal Muscular Atrophy</style> smatrial.enl EndNote 189 17 <style face="normal" font="default" size="100%">Activation of RNA metabolism-related genes in mouse but not human tissues deficient in SMN</style> smatrial.enl EndNote 293 17 <style face="normal" font="default" size="100%">Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization</style> smatrial.enl EndNote 395 17 <style face="normal" font="default" size="100%">Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade</style> smatrial.enl EndNote 1214 17 <style face="normal" font="default" size="100%">Acute and chronic effects of neurotrophic factors BDNF and GDNF on responses mediated by thermo-sensitive TRP channels in cultured rat dorsal root ganglion neurons</style> smatrial.enl EndNote 708 17 <style face="normal" font="default" size="100%">Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB</style> smatrial.enl EndNote 1040 17 <style face="normal" font="default" size="100%">Adenoviral gene transfer to spinal-cord neurons: intrathecal vs. intraparenchymal administration</style> smatrial.enl EndNote 667 17 <style face="normal" font="default" size="100%">Advances in signaling in vertebrate regeneration as a prelude to regenerative medicine</style> smatrial.enl EndNote 488 17 <style face="normal" font="default" size="100%">Advances in SMA research: review of gene deletions</style> smatrial.enl EndNote 328 17 <style face="normal" font="default" size="100%">AEG3482 is an antiapoptotic compound that inhibits Jun kinase activity and cell death through induced expression of heat shock protein 70</style> smatrial.enl EndNote 1280 17 <style face="normal" font="default" size="100%">Aerobic conditioning: an effective therapy in McArdle's disease</style> smatrial.enl EndNote 1282 17 <style face="normal" font="default" size="100%">Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy</style> smatrial.enl EndNote 1281 17 <style face="normal" font="default" size="100%">Aerobic training in patients with myotonic dystrophy type 1</style> smatrial.enl EndNote 1278 17 <style face="normal" font="default" size="100%">Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy</style> smatrial.enl EndNote 408 17 <style face="normal" font="default" size="100%">Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo</style> smatrial.enl EndNote 227 17 <style face="normal" font="default" size="100%">Allelic variants of the canine heavy neurofilament (NFH) subunit and extensive phosphorylation in dogs with motor neuron disease</style> smatrial.enl EndNote 1356 17 <style face="normal" font="default" size="100%">Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C</style> smatrial.enl EndNote 1340 17 <style face="normal" font="default" size="100%">Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice</style> smatrial.enl EndNote 1382 17 <style face="normal" font="default" size="100%">Altered RNA splicing contributes to skeletal muscle pathology in Kennedy disease knock-in mice</style> smatrial.enl EndNote 762 17 <style face="normal" font="default" size="100%">Altered synaptic plasticity in a mouse model of fragile X mental retardation</style> smatrial.enl EndNote 1304 17 <style face="normal" font="default" size="100%">Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy</style> smatrial.enl EndNote 1108 17 <style face="normal" font="default" size="100%">AMPK and PPARdelta agonists are exercise mimetics</style> smatrial.enl EndNote 23 17 <style face="normal" font="default" size="100%">An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene</style>